Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Shares Outstanding (2018 - 2026)

Viemed Healthcare filings provide 8 years of Shares Outstanding readings, the most recent being $38.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 2.85% to $38.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.0 million, a 2.85% decrease, with the full-year FY2025 number at $38.0 million, down 2.85% from a year prior.
  • Shares Outstanding hit $38.0 million in Q4 2025 for Viemed Healthcare, roughly flat from $38.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $39.6 million in Q4 2021 to a low of $38.0 million in Q3 2025.
  • Median Shares Outstanding over the past 5 years was $38.8 million (2024), compared with a mean of $38.8 million.
  • Biggest five-year swings in Shares Outstanding: grew 2.83% in 2021 and later decreased 4.01% in 2022.
  • Viemed Healthcare's Shares Outstanding stood at $39.6 million in 2021, then fell by 4.01% to $38.0 million in 2022, then increased by 1.2% to $38.5 million in 2023, then increased by 1.63% to $39.1 million in 2024, then dropped by 2.85% to $38.0 million in 2025.
  • The last three reported values for Shares Outstanding were $38.0 million (Q4 2025), $38.0 million (Q3 2025), and $39.6 million (Q2 2025) per Business Quant data.